Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Alerce Investment Management, L.P. (CIK 1844002) reported $56.8M across 5 reported positions in its SEC 13F filing for 2024-12-31. Largest positions: ANNX ($38.0M, 66.89%), AKBA ($10.9M, 19.23%), VRNA ($4.1M, 7.19%), AMWL ($3.8M, 6.69%), WHWK ($2,079, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ANNX | ANNEXON INC | $38.0M | 66.89% | 7.4M | Hold |
| 2 | AKBA | AKEBIA THERAPEUTICS INC | $10.9M | 19.23% | 5.7M | Hold |
| 3 | VRNA | VERONA PHARMA PLC | $4.1M | 7.19% | 88,000 | Trimmed |
| 4 | AMWL | AMERICAN WELL CORP | $3.8M | 6.69% | 523,785 | Hold |
| 5 | WHWK | AADI BIOSCIENCE INC | $2,079 | 0.00% | 659 | Hold |
Source: SEC Form 13F filings · as of 2024-12-31